Body Weight Loss by Very-Low-Calorie Diet Program Improves Small Artery Reactive Hyperemia in Severely Obese Patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Endothelial dysfunction is a major underlying mechanism for the elevated cardiovascular risk associated with increased body weight. We aimed to assess the impact of weight loss induced by an intensive very-low-calorie diet (VLCD) on arterial wall function in severely obese patients (SOP).
Thirty-four SOP were admitted to the metabolic ward of the hospital for a 3-week period. A VLCD characterized by a liquid diet providing 800 kcal/day was administered. The small artery reactivity to postischemic hyperemia index (saRHI), a surrogate marker of endothelial function, was assessed before and 1 week after hospital discharge. Anthropometry and biochemical parameters were also measured. Obese and non-obese age- and gender-matched groups were recruited for baseline comparisons.
SOP had significantly lower saRHI compared with obese and non-obese individuals. SaRHI significantly increased after the intervention in SOP (1.595 ± 0.236 vs. 1.737 ± 0.417, p = 0.015). A significant improvement in glucose (p = 0.026), systolic blood pressure (p = 0.049), LDLc (p < 0.001), and inflammatory parameters was observed. Body weight loss was associated with a higher saRHI (r = −0.385, p = 0.033), and it was the main determinant of saRHI variation independently of confounders (β −0.049, IC 95 % −0.091–0.008, p = 0.021).
Weight loss induced by a VLCD in SOP improved small artery reactivity, and it was associated with the amelioration of metabolic and inflammation markers. Endothelial dysfunction may be softened by body weight loss interventions and useful in the management of cardiovascular risk factors in SOP.
- Koplan JP, Dietz WH. Caloric imbalance and public health policy. JAMA. 1999;282:1579–81. CrossRef
- Pi-Sunyer X, Kris-Etherton PM. Improving health outcomes: future directions in the field. J Am Diet Assoc. 2005;105:S14–6. CrossRef
- Salas-Salvado J, Rubio MA, Barbany M, et al. SEEDO 2007 consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria. Med Clin (Barc). 2007;128:184–96. CrossRef
- Grassi G, Seravalle G, Scopelliti F, et al. Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity. Obesity (Silver Spring). 2010;18:92–8. CrossRef
- Brook RD. Obesity, weight loss, and vascular function. Endocrine. 2006;29:21–5. CrossRef
- Mavri A, Poredos P, Suran D, et al. Effect of diet-induced weight loss on endothelial dysfunction: early improvement after the first week of dieting. Hear Vessel. 2011;26:31–8. CrossRef
- Nerla R, Tarzia P, Sestito A, et al. Effect of bariatric surgery on peripheral flow-mediated dilation and coronary microvascular function. Nutr Metab Cardiovasc Dis. 2012;8:626–34.
- Shechter M, Beigel R, Freimark D, et al. Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease. Am J Cardiol. 2006;97:1650–3. CrossRef
- Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008;117:2467–74. CrossRef
- Hamburg NM, Palmisano J, Larson MG, et al. Relation of brachial and digital measures of vascular function in the community: the Framingham Heart Study. Hypertension. 2011;57:390–6. CrossRef
- Boari GE, Rizzoni D, De Ciuceis C, et al. Structural alterations in subcutaneous small resistance arteries predict changes in the renal function of hypertensive patients. J Hypertens. 2010;28:1951–8. CrossRef
- Ferre R, Aragones G, Plana N, et al. High-density lipoprotein cholesterol and apolipoprotein A1 levels strongly influence the reactivity of small peripheral arteries. Atherosclerosis. 2011;216:115–9. CrossRef
- Ferre R, Plana N, Merino J, et al. Effects of therapeutic lifestyle changes on peripheral artery tonometry in patients with abdominal obesity. Nutr Metab Cardiovasc Dis. 2012;2:95–102.
- Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10years after bariatric surgery. N Engl J Med. 2004;351:2683–93. CrossRef
- Athyros VG, Tziomalos K, Karagiannis A, et al. Cardiovascular benefits of bariatric surgery in morbidly obese patients. Obes Rev. 2011;12:515–24. CrossRef
- Baker S, Jerums G, Proietto J. Effects and clinical potential of very-low-calorie diets (VLCDs) in type 2 diabetes. Diabetes Res Clin Pract. 2009;85:235–42. CrossRef
- Keogh JB, Brinkworth GD, Noakes M, et al. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008;87:567–76.
- Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9. CrossRef
- Pierce GL, Beske SD, Lawson BR, et al. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension. 2008;52:72–9. CrossRef
- Habib P, Scrocco JD, Terek M, et al. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol. 2009;104:1251–5. CrossRef
- Raitakari M, Ilvonen T, Ahotupa M, et al. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004;24:124–8. CrossRef
- Rudofsky G, Roeder E, Merle T, et al. Weight loss improves endothelial function independently of ADMA reduction in severe obesity. Horm Metab Res. 2011;43:343–8. CrossRef
- Aragonès G, Ferré R, Girona J, et al. Small artery dilation and endothelial markers in cardiovascular risk patients. Eur J Clin Invest. 2012;1:34–41.
- Tanigaki K, Mineo C, Yuhanna IS, et al. C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1. Circ Res. 2009;104:1275–82. CrossRef
- Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des. 2008;14:1225–30. CrossRef
- Hamburg NM, Benjamin EJ. Assessment of endothelial function using digital pulse amplitude tonometry. Trends Cardiovasc Med. 2009;19:6–11. CrossRef
- Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension. 1992;19:I67–77. CrossRef
- Grassi G, Seravalle G, Colombo M, et al. Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation. 1998;97:2037–42. CrossRef
- Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001;19:523–8. CrossRef
- Handa P, Tateya S, Rizzo NO, et al. Reduced vascular nitric oxide-cGMP signaling contributes to adipose tissue inflammation during high-fat feeding. Arterioscler Thromb Vasc Biol. 2011;31:2827–35. CrossRef
- Body Weight Loss by Very-Low-Calorie Diet Program Improves Small Artery Reactive Hyperemia in Severely Obese Patients
Volume 23, Issue 1 , pp 17-23
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Very-low-calorie diet
- Small artery reactive hyperemia
- Severe obesity
- Body weight loss
- Endothelial function
- Industry Sectors
- Author Affiliations
- 1. Vascular Medicine and Metabolism Unit, Lipids and Atherosclerosis Research Unit, Sant Joan University Hospital, Institut d’Investigació Sanitària Pere Virgili (IISPV), Faculty of Medicine, Universitat Rovira i Virgili—Spanish Biomedical Research Network in Diabetes and Associated Metabolic Disorders (CIBERDEM), Barcelona, Spain
- 2. Dietetics and Nutrition Unit, Sant Joan University Hospital—Reus, Reus, Spain